Pregled bibliografske jedinice broj: 1238481
The Chloroquine Story in the First Year of the COVID-19 Pandemic
The Chloroquine Story in the First Year of the COVID-19 Pandemic // Kemija u industriji, 71 (2022), 473-484 doi:10.15255/KUI.2021.072 (recenziran, pregledni rad, znanstveni)
CROSBI ID: 1238481 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Chloroquine Story in the First Year of the
COVID-19 Pandemic
Autori
Hunić, Mateja ; Teparić, Renata ; Kovačević, Monika ; Barišić, Lidija
Izvornik
Kemija u industriji (0022-9830) 71
(2022);
473-484
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Chemical synthesis ; chloroquine ; COVID-19 ; hydroxychloroquine ; SARS-CoV-2
Sažetak
The emergence of COVID-19 has caused worldwide concern due to its high infectivity and mortality. Research groups around the world have prioritised drug development against COVID-19. Repurposing of already approved drugs, including the antimalarial drug chloroquine, has attracted considerable attention. The aim of this article is to (i) provide an overview of the recent chemical methods used to synthesise chloroquine and hydroxychloroquine, and (ii) provide insight into the data collected in 2020 on their efficacy against COVID-19. Unfortunately, the promising early results have not been confirmed and a clear and unambiguous conclusion on their clinical efficacy has not yet been drawn.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Interdisciplinarne prirodne znanosti, Biotehnologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Prehrambeno-biotehnološki fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
Uključenost u ostale bibliografske baze podataka::
- Analytical Abstracts
- Chemical Engineering and Biotechnology Abstracts
